Medicine use index (2020=100) vs Oncology novel active substance (NAS) launches (cumulative) in China
In 2020, medicine use index (2020=100) in China was 100 index; oncology novel active substance (NAS) launches (cumulative) was 84.
Change the pair
Compare different indicators
The series
Over time
China, spaced by time in 2020 . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.
Medicine use index (2020=100)
Unit: index · 1 observation
View the underlying data
| Period | Type | Value |
|---|---|---|
| 2020 | Actual | 100 index |
Oncology novel active substance (NAS) launches (cumulative)
Unit: count · 1 observation
View the underlying data
| Period | Type | Value |
|---|---|---|
| 2020–2024 | Actual | 84 |
Shared periods
Side by side
Only one period is published for both series in China. Comparing anything else would mean comparing different years.
Provenance
Where these numbers come from
Medicine use index (2020=100)
Index of medicine usage relative to a 2020 baseline of 100.
2 observations in China · source organisations: IQVIA
Oncology novel active substance (NAS) launches (cumulative)
Total number of oncology novel active substances launched over a stated multi-year period.
2 observations in China · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring